On progression-free interval (PFI) analysis, SAAL1 was a risk factor in ACC (HR=1.865, P<0.001), KICH (HR=2.862, P<0.001), KIRC (HR=1.369, P<0.001), KIRP (HR=1.663, P<0.001), LGG (HR=1.113, P=0.039), LIHC (HR=1.141, P=0.003), LUAD (HR=1.089, P=0.022), MESO (HR=1.250, P=0.009), PCPG (HR=1.348, P=0.002), PRAD (HR=1.138, P=0.007), and UCS (HR=1.147, P=0.035) (Figure 4C). Here, SAAL1 is linked to adrenal cortex carcinoma.